Evidence map›Paper›PMID 23344198›Full record

ArticleMolecules (Basel, Switzerland)2013

Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.

Seo-Jin Kim, Jae-Seok Kim, Yoo-Sup Lee, Dae-Won Sim, Sung-Hee Lee, Young-Yil Bahk, Kwang-Ho Lee, Eun-Hee Kim, Sung-Jean Park, Bong-Jin Lee and 1 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Latarcins: versatile spider venom peptides.Cellular and molecular life sciences : CMLS · 2015
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Seo-Jin KimDepartment of Biotechnology, Research Institute for Biomedical and Health Science, College of Biomedical and Health Science, Konkuk University, Chungju, Chungbuk 380-701, Korea.
Jae-Seok Kim
Yoo-Sup Lee
Dae-Won Sim
Sung-Hee Lee
Young-Yil Bahk
Kwang-Ho Lee
Eun-Hee Kim
Sung-Jean Park
Bong-Jin Lee
Hyung-Sik Won

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In an effort to develop short antimicrobial peptides with simple amino acid compositions, we generated a series of undecapeptide isomers having the L(5)K(5)W formula. Amino acid sequences were designed to be perfectly amphipathic when folded into a helical conformation by converging leucines onto one side and lysines onto the other side of the helical axis. The single tryptophans, whose positions were varied in the primary structures, were located commonly at the critical amphipathic interface in the helical wheel projection. Helical conformations and the tryptophanyl environments of the 11 L(5)K(5)W peptides were confirmed and characterized by circular dichroism, fluorescence and nuclear magnetic resonance spectroscopy. All of the isomers exhibited a potent, broad-spectrum of antibacterial activity with just a slight variance in individual potency, whereas their hemolytic activities against human erythrocytes were significantly diversified. Interestingly, helical dispositions and fluorescence blue shifts of the peptides in aqueous trifluoroethanol solutions, rather than in detergent micelles, showed a marked linear correlation with their hemolytic potency. These results demonstrate that our de novo design strategy for amphipathic helical model peptides is effective for developing novel antimicrobial peptides and their hemolytic activities can be estimated in correlation with structural parameters.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsAntimicrobial Cationic PeptidesCell Membrane PermeabilityDrug DesignErythrocytesGram-Negative BacteriaHemolytic AgentsHumansHydrophobic and Hydrophilic InteractionsIsomerismMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsOligopeptidesProtein Structure, SecondaryStructure-Activity RelationshipAnti-Bacterial AgentsAntimicrobial Cationic PeptidesHemolytic AgentsOligopeptidesTryptophan

Identifiers

PMID23344198
PMCPMC6270530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.